These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31586799)

  • 81. 5 -Alpha-dihydroxyprogesterone may contribute to perceptual processing and attention of the cases with relapsing remitting multiple sclerosis.
    Ozcan E; Akduman RC; Eyupoglu S; Bingol A; Balci Ekmekci O; Hatipoglu E
    Neurol Res; 2024 Feb; 46(2):132-138. PubMed ID: 37733038
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis.
    Waldman AT; Chahin S; Lavery AM; Liu G; Banwell BL; Liu GT; Balcer LJ
    Mult Scler Relat Disord; 2016 Nov; 10():73-78. PubMed ID: 27919503
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis.
    Parmenter BA; Zivadinov R; Kerenyi L; Gavett R; Weinstock-Guttman B; Dwyer MG; Garg N; Munschauer F; Benedict RH
    J Clin Exp Neuropsychol; 2007 Feb; 29(2):215-23. PubMed ID: 17365256
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
    Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
    J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers.
    Fenu G; Fronza M; Lorefice L; Arru M; Coghe G; Frau J; Marrosu MG; Cocco E
    BMC Neurol; 2018 Dec; 18(1):212. PubMed ID: 30567519
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
    Pakdaman H; Amini Harandi A; Gharagozli K; Abbasi M; Tabassi A; Ashrafi F; Ghaffarpor M; Sharifi S; Delavar Kasmae H; Assarzadegan F; Arabahmadi M; Behnam B
    Int J Neurosci; 2017 Jun; 127(6):501-507. PubMed ID: 27279451
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
    van Gorp DAM; van der Hiele K; Heerings MAP; Jongen PJ; van der Klink JJL; Reneman MF; Arnoldus EPJ; Beenakker EAC; van Eijk JJJ; Frequin STFM; de Gans K; Hoitsma E; Mostert JP; Verhagen WIM; Zemel D; Visser LH; Middelkoop HAM
    Neurol Sci; 2019 Dec; 40(12):2555-2564. PubMed ID: 31321625
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
    Hojjat SP; Cantrell CG; Vitorino R; Feinstein A; Shirzadi Z; MacIntosh BJ; Crane DE; Zhang L; Morrow SA; Lee L; O'Connor P; Carroll TJ; Aviv RI
    Mult Scler; 2016 Oct; 22(11):1421-1428. PubMed ID: 26754799
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Cognitive impairment after three decades of multiple sclerosis.
    Smestad C; Sandvik L; Landrø NI; Celius EG
    Eur J Neurol; 2010 Mar; 17(3):499-505. PubMed ID: 20050887
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions.
    Gajofatto A; Turatti M; Bianchi MR; Forlivesi S; Gobbin F; Azzarà A; Monaco S; Benedetti MD
    Acta Neurol Scand; 2016 Mar; 133(3):183-91. PubMed ID: 26009804
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice.
    Coyle PK; Khatri B; Edwards KR; Meca-Lallana JE; Cavalier S; Rufi P; Benamor M; Thangavelu K; Robinson M; Gold R;
    Mult Scler Relat Disord; 2018 Nov; 26():211-218. PubMed ID: 30273841
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Positive Correlation of Serum Adiponectin with Lipid Profile in Patients with Type 2 Diabetes Mellitus is Affected by Metabolic Syndrome Status.
    Eslamian M; Mohammadinejad P; Aryan Z; Nakhjavani M; Esteghamati A
    Arch Iran Med; 2016 Apr; 19(4):269-74. PubMed ID: 27041522
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis.
    Castillo-Triviño T; Gómez-Ballesteros R; Borges M; Martín-Martínez J; Sotoca J; Alonso A; Caminero AB; Borrega L; Sánchez-Menoyo JL; Barrero-Hernández FJ; Calles C; Brieva L; Blasco-Quílez MR; García-Soto JD; Del Campo-Amigo M; Navarro-Cantó L; Agüera E; Garcés-Redondo M; Carmona O; Gabaldón-Torres L; Forero L; Hervás M; Mauriño J; Sainz de la Maza S
    Mult Scler Relat Disord; 2022 Aug; 64():103969. PubMed ID: 35728432
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery.
    Berard JA; Walker LAS
    Mult Scler Relat Disord; 2022 Jul; 63():103865. PubMed ID: 35580469
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immediate effect of two yoga-based relaxation techniques on cognitive functions in patients suffering from relapsing remitting multiple sclerosis: A comparative study.
    Bhargav P; Bhargav H; Raghuram N; Garner C
    Int Rev Psychiatry; 2016 Jun; 28(3):299-308. PubMed ID: 27299568
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association of Retinal Layer Thickness With Cognition in Patients With Multiple Sclerosis.
    Baetge SJ; Dietrich M; Filser M; Renner A; Stute N; Gasis M; Weise M; Lepka K; Graf J; Goebels N; Hartung HP; Aktas O; Meuth S; Albrecht P; Penner IK
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34045307
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
    Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
    Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Olfactory Dysfunction and Cognition in Radiologically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis.
    Arici Duz O; Saatci O; Karakulak EZ; Birday E; Hanoglu L
    Eur Neurol; 2021; 84(3):175-182. PubMed ID: 33831865
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Insulin resistance is associated with cognitive dysfunction in multiple sclerosis patients: A cross-sectional study.
    Ayromlou H; Hosseini S; Khalili M; Ayromlou S; Khamudchiyan S; Farajdokht F; Hassannezhad S; Amiri Moghadam S
    J Neuroendocrinol; 2023 Jun; 35(6):e13288. PubMed ID: 37317829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.